TESTOSTERONE REPLACEMENT THERAPY AFTER PRIMARY TREATMENT FOR PROSTATE CANCER
- 1 February 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 173 (2) , 533-536
Abstract
A history of prostate cancer has been an absolute contraindication for testosterone supplementation. We studied a cohort of hypogonadal patients treated with radical retropubic prostatectomy (RRP) for organ confined prostate cancer to determine if testosterone replacement therapy (TRT) could be efficacious and administered safely without causing recurrent prostate tumor. Ten hypogonadal patients previously treated with RRP for organ confined prostate cancer were identified. They presented with low serum total testosterone (TT) and symptoms of hypogonadism after RRP. Patients had baseline serum determinations of prostate specific antigen (PSA) and TT, and were started on testosterone supplementation. They were assessed periodically for changes in PSA and TT, and for symptomatic improvement using the hormone domain of the Extended Prostate Inventory Composite Health Related Quality of Life questionnaire. At a median followup of 19 months no patient had detectable (greater than 0.1 ng/ml) PSA. TT increased significantly after starting TRT from a mean ± SD of 197 ± 67 to 591 ± 180 ng/dl (p = 0.0002). The Hormone Domain of the Extended Prostate Inventory Composite Health Related Quality of Life questionnaire increased significantly from 38 ± 5 to 49 ± 3 (p = 0.00005), primarily due to a decrease in hot flashes and an increase in energy level. At a median of 19 months of TRT hypogonadal patients with a history of prostate cancer had no PSA recurrence and had statistically significant improvements in TT and hypogonadal symptoms. In highly select patients after RRP TRT can be administered carefully and with benefit to hypogonadal patients with prostate cancer.Keywords
This publication has 19 references indexed in Scilit:
- Risks of Testosterone-Replacement Therapy and Recommendations for MonitoringNew England Journal of Medicine, 2004
- Testosterone Replacement Therapy in Hypogonadal Men at High Risk for Prostate Cancer: Results of 1 Year of Treatment in Men With Prostatic Intraepithelial NeoplasiaJournal of Urology, 2003
- Pretreatment Total Testosterone Level Predicts Pathological Stage in Patients With Localized Prostate Cancer Treated With Radical ProstatectomyJournal of Urology, 2003
- Testosterone Gel Supplementation for Men With Refractory Depression: A Randomized, Placebo-Controlled TrialAmerican Journal of Psychiatry, 2003
- Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy MenThe Journal of Clinical Endocrinology & Metabolism, 2001
- Effects of Testosterone Replacement in Hypogonadal Men1The Journal of Clinical Endocrinology & Metabolism, 2000
- IS LOW SERUM FREE TESTOSTERONE A MARKER FOR HIGH GRADE PROSTATE CANCER?Journal of Urology, 2000
- INFLUENCE OF RADICAL PROSTATECTOMY ON SERUM HORMONE LEVELSJournal of Urology, 1998
- Prostate Cancer after Exogenous Testosterone Treatment for ImpotenceJournal of Urology, 1997
- STUDIES ON PROSTATIC CANCERArchives of Surgery, 1941